PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsLevalbuterol
Levosalbutamol
Levosalbutamol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-2 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Levalbuterol, Xopenex (discontinued: Levalbuterol, Xopenex)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Levalbuterol tartrate
Tradename
Company
Number
Date
Products
XOPENEX HFALupin ResearchN-021730 RX2005-03-11
1 products, RLD, RS
Levalbuterol hydrochloride
Tradename
Company
Number
Date
Products
XOPENEXHikma PharmaceuticalsN-020837 DISCN1999-03-25
4 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
levalbuterolANDA2024-12-24
levalbuterol hydrochlorideANDA2015-07-15
levalbuterol inhalationANDA2024-12-19
levalbuterol inhalation solutionANDA2020-04-23
levalbuterol tartrate hfa inhalationNDA authorized generic2024-01-15
tetracycline hydrochlorideANDA2016-05-20
xopenexNew Drug Application2022-09-14
xopenex hfaNew Drug Application2024-01-01
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bronchial spasm—D001986—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
652 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J45——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLevosalbutamol
INNlevosalbutamol
Description
(R)-salbutamol is an albuterol.
Classification
Small molecule
Drug classanti-inflammatory agents (salicylic acid derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1
Identifiers
PDB—
CAS-ID34391-04-3
RxCUI—
ChEMBL IDCHEMBL1002
ChEBI ID8746
PubChem CID123600
DrugBankDB13139
UNII IDEDN2NBH5SS (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
154
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Q9UMZ5
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Levosalbutamol
+
Levalbuterol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,125 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use